Latest news with #WCH
Business Standard
5 days ago
- Health
- Business Standard
A Proud Moment for India: IHRO Chief Honored with Prestigious Royal Maharlika Award in the USA
VMPL New Delhi [India], May 31: Today marks a proud moment for India as renowned human rights activist and champion of Ambedkarite ideals, Dr. Nem Singh Premi, brought great honour to the country. For his remarkable global contributions to the field of human rights, he was conferred with the prestigious "Royal Maharlika Award" in a grand ceremony held in Las Vegas, USA. Dr. Premi also addressed the gathering as a distinguished guest during the award event. In recent global discussions, alongside praise for the social welfare policies of UN Secretary-General Antonio Guterres, Dr. Premi's recognition as a Royal Maharlika laureate has drawn considerable international attention. Notably, during the 7th WCH Royal Summit, held in Las Vegas, Dr. Premi was also knighted for his outstanding humanitarian service. Dr. Nem Singh Premi is the President of the International Human Rights Organization (IHRO), headquartered in New Delhi. He is recognized in over 50 countries for his tireless efforts in championing human rights. Over the years, he has played a critical role in several humanitarian missions, such as saving 17 Indians from the death penalty in Sharjah and repatriating 400 bonded laborers from Libya. He gained global acclaim when he boldly condemned the Iranian government's religious bias against the Baha'i community at the United Nations, advocating for their rights. During the COVID-19 pandemic, he established a 400-bed hospital to aid those in need, another testament to his commitment to public welfare. Under his leadership, IHRO has expanded its presence across more than 50 countries. In India, his work has made a deep impact, particularly in the states of Punjab, Chhattisgarh, Arunachal Pradesh, and Maharashtra, where countless individuals have received justice through the organization's intervention. The Royal Maharlika Awards are presented annually to honor "Guardians of the Earth," peacebuilders, and changemakers from around the world. The award recognizes individuals who have demonstrated exceptional dedication to justice and human dignity. The event was presided over by Queen Mariam Leonora Torres Mastura, President and Founder of We Care for Humanity (WCH), and a descendant of the Royal House of Luzon Tagalog and the Maguindanao Sultanate. On May 27, 2025, the 7th WCH Royal Summit was held in the Nevada Ballroom at the Gold Coast Hotel. Distinguished guests, royalty, and global leaders gathered to engage in meaningful dialogue on humanitarianism, peace, and sustainable development. The summit was convened by Princess Mariam Leonora Torres Mastura in collaboration with We Care for Humanity (WCH), the Royal Maharlika, the Maguindanao Sultanate, and the Honorary Philippine Consulate in Las Vegas. The summit successfully brought together diverse voices and perspectives, reinforcing global commitments to collaborative humanitarian efforts and building a better future for all. About the Organizers: We Care for Humanity (WCH) is an internationally recognized non-profit advocating for peace, human rights, and sustainable development. The Royal Maharlika and the Maguindanao Sultanate are esteemed cultural institutions dedicated to preserving tradition and advancing community welfare.
Yahoo
6 days ago
- Business
- Yahoo
Wacker Chemie AG's (ETR:WCH) Intrinsic Value Is Potentially 81% Above Its Share Price
The projected fair value for Wacker Chemie is €114 based on 2 Stage Free Cash Flow to Equity Current share price of €63.05 suggests Wacker Chemie is potentially 45% undervalued Analyst price target for WCH is €85.80 which is 25% below our fair value estimate Does the May share price for Wacker Chemie AG (ETR:WCH) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by projecting its future cash flows and then discounting them to today's value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. Before you think you won't be able to understand it, just read on! It's actually much less complex than you'd imagine. We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (€, Millions) €219.3m €416.3m €382.3m €346.0m €325.1m €312.6m €305.4m €301.7m €300.2m €300.3m Growth Rate Estimate Source Analyst x4 Analyst x4 Analyst x3 Analyst x1 Est @ -6.03% Est @ -3.84% Est @ -2.31% Est @ -1.23% Est @ -0.48% Est @ 0.04% Present Value (€, Millions) Discounted @ 6.3% €206 €369 €319 €271 €240 €217 €200 €186 €174 €164 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = €2.3b The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 1.3%. We discount the terminal cash flows to today's value at a cost of equity of 6.3%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = €300m× (1 + 1.3%) ÷ (6.3%– 1.3%) = €6.1b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= €6.1b÷ ( 1 + 6.3%)10= €3.3b The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is €5.7b. In the final step we divide the equity value by the number of shares outstanding. Relative to the current share price of €63.1, the company appears quite undervalued at a 45% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Wacker Chemie as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.3%, which is based on a levered beta of 1.152. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. View our latest analysis for Wacker Chemie Strength Debt is well covered by earnings. Weakness Earnings declined over the past year. Dividend is low compared to the top 25% of dividend payers in the Chemicals market. Opportunity Annual earnings are forecast to grow faster than the German market. Good value based on P/E ratio and estimated fair value. Threat Debt is not well covered by operating cash flow. Paying a dividend but company has no free cash flows. Annual revenue is forecast to grow slower than the German market. Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. DCF models are not the be-all and end-all of investment valuation. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. Why is the intrinsic value higher than the current share price? For Wacker Chemie, we've compiled three fundamental factors you should assess: Risks: For example, we've discovered 1 warning sign for Wacker Chemie that you should be aware of before investing here. Future Earnings: How does WCH's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the XTRA every day. If you want to find the calculation for other stocks just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
13-05-2025
- Business
- Associated Press
Scope Technologies Corp. Joins Forces with World Cyber Health to Advance Global Quantum Security Standards
VANCOUVER, BC, May 13, 2025 /PRNewswire/ -- Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ('Scope Technologies' or the 'Company'), a pioneer in quantum-resilient data protection solutions, is pleased to announce a strategic collaboration with World Cyber Health (WCH), the global non-profit initiative behind Malware Village. This collaboration supports WCH's mission to advance global awareness of post-quantum cryptography (PQC) threats and to promote consistent international standards for quantum-era cybersecurity readiness. Scope Technologies will contribute expertise from its Quantum Security Entropy (QSE) platform to support WCH's efforts in educating public and private sector stakeholders about the systemic risks posed by emerging quantum technologies. Scope will also assist WCH in advocating for globally aligned system compliance and readiness frameworks to mitigate these next-generation risks. 'Quantum threats are no longer hypothetical—they're on the horizon,' said James Young, CEO of Scope Technologies. 'We're proud to support World Cyber Health in its mission to prepare organizations and governments for the coming shift in digital security. Collaboration and education are key to ensuring data safety in the quantum era.' The collaboration will include ongoing knowledge sharing, advocacy, and joint participation in high-profile cybersecurity events. Scope Technologies is currently exploring opportunities to participate in upcoming public forums, including a potential speaking engagement at DEFCON 33 in Las Vegas, this August, hosted by the world's largest and most influential hacker conference. For more information on World Cyber Health and Malware Village, visit To learn more about Scope Technologies and its quantum-secure platform QSE, visit About Scope Technologies Corp Headquartered in Vancouver, British Columbia, Scope Technologies Corp is a pioneering technology company specializing in quantum security and machine learning. Through its flagship brands, QSE Group and GEM AI, Scope provides next-generation solutions in data security, quantum encryption, and neural networks, empowering businesses with secure, scalable technologies that drive growth and operational efficiency. LinkedIn: scope-technologies-corp Facebook: Scope Technologies Corp Twitter: @ScopeTechCorp Contact Information: James Young CEO, Scope Technologies Corp. Email: [email protected] Phone: +1 604-416-1720 Website: Cautionary Note Regarding Forward-Looking Statements This news release contains forward-looking statements that constitute forward-looking information (collectively, 'forward-looking statements') within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements and include statements regarding beliefs, plans, expectations, future, strategy, objectives, goals and targets, and more specifically, the use of proceeds of the Offering. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: 'believes', 'expects', 'aim', 'anticipates', 'intends', 'estimates', 'plans', 'may', 'should', 'would', 'will', 'potential', 'scheduled' or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. Forward-looking statements involve known and unknown risks and are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, including, but not limited to, those risks and assumptions described in the Company's latest management discussion and analysis, a copy of which is available under the Company's profile on SEDAR at While Scope considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this press release. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions, continued satisfaction of Canadian Securities Exchange requirements, product safety and recalls, regulatory compliance and risks associated with the Company's business. Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement. The Canadian Securities Exchange has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof. Logo: View original content: SOURCE Scope Technologies Corp.
Yahoo
13-05-2025
- Business
- Yahoo
Scope Technologies Corp. Joins Forces with World Cyber Health to Advance Global Quantum Security Standards
VANCOUVER, BC, May 13, 2025 /CNW/ -- Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("Scope Technologies" or the "Company"), a pioneer in quantum-resilient data protection solutions, is pleased to announce a strategic collaboration with World Cyber Health (WCH), the global non-profit initiative behind Malware Village. This collaboration supports WCH's mission to advance global awareness of post-quantum cryptography (PQC) threats and to promote consistent international standards for quantum-era cybersecurity readiness. Scope Technologies will contribute expertise from its Quantum Security Entropy (QSE) platform to support WCH's efforts in educating public and private sector stakeholders about the systemic risks posed by emerging quantum technologies. Scope will also assist WCH in advocating for globally aligned system compliance and readiness frameworks to mitigate these next-generation risks. "Quantum threats are no longer hypothetical—they're on the horizon," said James Young, CEO of Scope Technologies. "We're proud to support World Cyber Health in its mission to prepare organizations and governments for the coming shift in digital security. Collaboration and education are key to ensuring data safety in the quantum era." The collaboration will include ongoing knowledge sharing, advocacy, and joint participation in high-profile cybersecurity events. Scope Technologies is currently exploring opportunities to participate in upcoming public forums, including a potential speaking engagement at DEFCON 33 in Las Vegas, this August, hosted by the world's largest and most influential hacker conference. For more information on World Cyber Health and Malware Village, visit To learn more about Scope Technologies and its quantum-secure platform QSE, visit About Scope Technologies Corp Headquartered in Vancouver, British Columbia, Scope Technologies Corp is a pioneering technology company specializing in quantum security and machine learning. Through its flagship brands, QSE Group and GEM AI, Scope provides next-generation solutions in data security, quantum encryption, and neural networks, empowering businesses with secure, scalable technologies that drive growth and operational efficiency. LinkedIn: scope-technologies-corpFacebook: Scope Technologies CorpTwitter: @ScopeTechCorp Contact Information: James YoungCEO, Scope Technologies james@ Phone: +1 604-416-1720Website: Cautionary Note Regarding Forward-Looking Statements This news release contains forward-looking statements that constitute forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements and include statements regarding beliefs, plans, expectations, future, strategy, objectives, goals and targets, and more specifically, the use of proceeds of the Offering. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "would", "will", "potential", "scheduled" or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. Forward-looking statements involve known and unknown risks and are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, including, but not limited to, those risks and assumptions described in the Company's latest management discussion and analysis, a copy of which is available under the Company's profile on SEDAR at While Scope considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this press release. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions, continued satisfaction of Canadian Securities Exchange requirements, product safety and recalls, regulatory compliance and risks associated with the Company's business. Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement. The Canadian Securities Exchange has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof. Logo: View original content: SOURCE Scope Technologies Corp. View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Cision Canada
13-05-2025
- Business
- Cision Canada
Scope Technologies Corp. Joins Forces with World Cyber Health to Advance Global Quantum Security Standards
VANCOUVER, BC, May 13, 2025 /CNW/ -- Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("Scope Technologies" or the "Company"), a pioneer in quantum-resilient data protection solutions, is pleased to announce a strategic collaboration with World Cyber Health (WCH), the global non-profit initiative behind Malware Village. This collaboration supports WCH's mission to advance global awareness of post-quantum cryptography (PQC) threats and to promote consistent international standards for quantum-era cybersecurity readiness. Scope Technologies will contribute expertise from its Quantum Security Entropy (QSE) platform to support WCH's efforts in educating public and private sector stakeholders about the systemic risks posed by emerging quantum technologies. Scope will also assist WCH in advocating for globally aligned system compliance and readiness frameworks to mitigate these next-generation risks. "Quantum threats are no longer hypothetical—they're on the horizon," said James Young, CEO of Scope Technologies. "We're proud to support World Cyber Health in its mission to prepare organizations and governments for the coming shift in digital security. Collaboration and education are key to ensuring data safety in the quantum era." The collaboration will include ongoing knowledge sharing, advocacy, and joint participation in high-profile cybersecurity events. Scope Technologies is currently exploring opportunities to participate in upcoming public forums, including a potential speaking engagement at DEFCON 33 in Las Vegas, this August, hosted by the world's largest and most influential hacker conference. For more information on World Cyber Health and Malware Village, visit To learn more about Scope Technologies and its quantum-secure platform QSE, visit About Scope Technologies Corp Headquartered in Vancouver, British Columbia, Scope Technologies Corp is a pioneering technology company specializing in quantum security and machine learning. Through its flagship brands, QSE Group and GEM AI, Scope provides next-generation solutions in data security, quantum encryption, and neural networks, empowering businesses with secure, scalable technologies that drive growth and operational efficiency. Contact Information: James Young CEO, Scope Technologies Corp. Email: [email protected] Phone: +1 604-416-1720 Website: Cautionary Note Regarding Forward-Looking Statements This news release contains forward-looking statements that constitute forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements and include statements regarding beliefs, plans, expectations, future, strategy, objectives, goals and targets, and more specifically, the use of proceeds of the Offering. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "would", "will", "potential", "scheduled" or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. Forward-looking statements involve known and unknown risks and are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, including, but not limited to, those risks and assumptions described in the Company's latest management discussion and analysis, a copy of which is available under the Company's profile on SEDAR at While Scope considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this press release. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions, continued satisfaction of Canadian Securities Exchange requirements, product safety and recalls, regulatory compliance and risks associated with the Company's business. Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement.
